Correlation Between Nanologix and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Nanologix and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanologix and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanologix and Novo Nordisk AS, you can compare the effects of market volatilities on Nanologix and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanologix with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanologix and Novo Nordisk.
Diversification Opportunities for Nanologix and Novo Nordisk
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Nanologix and Novo is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Nanologix and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Nanologix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanologix are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Nanologix i.e., Nanologix and Novo Nordisk go up and down completely randomly.
Pair Corralation between Nanologix and Novo Nordisk
Given the investment horizon of 90 days Nanologix is expected to generate 21.52 times more return on investment than Novo Nordisk. However, Nanologix is 21.52 times more volatile than Novo Nordisk AS. It trades about 0.04 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.03 per unit of risk. If you would invest 0.01 in Nanologix on October 11, 2024 and sell it today you would earn a total of 0.00 from holding Nanologix or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Nanologix vs. Novo Nordisk AS
Performance |
| Timeline |
| Nanologix |
| Novo Nordisk AS |
Nanologix and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nanologix and Novo Nordisk
The main advantage of trading using opposite Nanologix and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanologix position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Nanologix vs. Madrigal Pharmaceuticals | Nanologix vs. Viking Therapeutics | Nanologix vs. Sarepta Therapeutics | Nanologix vs. Hepion Pharmaceuticals |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |